Vijaya Sunkara, MD
Internal Medicine · Ashburn, VANPI 1871548255
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Exact Sciences at 43.2% of the total. 2025 is the largest year on record at $63, 2.9 times the $22 reported in 2022. That places this record below the midpoint for internal medicine clinicians in VA, where the typical reported total is $141.
Across 5 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$44
- Mylan Specialty L.p.$22
- Corcept Therapeutics$18
- Lundbeck LLC$18
What the payments were for
- Food & beverage$102100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 2 | $44 |
| Mylan Specialty L.p. | 1 | $22 |
| Corcept Therapeutics | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
How this compares
$102 in reported general payments places this provider in the 40th percentile of 2,724 internal medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 102 | $73,800 |
| XareltoRivaroxaban | 26 | $31,000 |
| MyrbetriqMirabegron | 29 | $24,014 |
| JardianceEmpagliflozin | 11 | $13,313 |
| GemtesaVibegron | 14 | $11,705 |
| TradjentaLinagliptin | 13 | $9,899 |
| FarxigaDapagliflozin Propanediol | 15 | $8,766 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $8,021 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $7,286 |
| Rivastigmine | 21 | $2,939 |
| Lidocaine | 17 | $2,911 |
| Levothyroxine Sodium | 193 | $2,528 |
| SynthroidLevothyroxine Sodium | 26 | $2,403 |
| Atorvastatin Calcium | 204 | $2,389 |
| Escitalopram Oxalate | 144 | $2,237 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Ashburn
- Amr BehiriAshburn$15K
- Kumar AbhishekMechanicsville$1M
- Amit MahajanFalls Church$1M
- Kevin DonohueFalls Church$655K
- Denise BrunerArlington$227K
- Anjali KaloreMidlothian$215K
- Scott GerrishVienna$207K
- Lawrence SchwartzRichmond$205K
- Wally SmithRichmond$177K
- Gautam GulatiMc Lean$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.